Chlorine in PDB 3w69: Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
Protein crystallography data
The structure of Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor, PDB code: 3w69
was solved by
H.Shimizu,
S.Katakura,
M.Miyazaki,
H.Naito,
Y.Sugimoto,
H.Kawato,
T.Okayama,
T.Soga,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
21.18 /
1.90
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
53.562,
65.761,
81.436,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.9 /
23.8
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
(pdb code 3w69). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor, PDB code: 3w69:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 3w69
Go back to
Chlorine Binding Sites List in 3w69
Chlorine binding site 1 out
of 4 in the Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl201
b:29.0
occ:1.00
|
CL2
|
A:LTZ201
|
0.0
|
29.0
|
1.0
|
C30
|
A:LTZ201
|
1.8
|
29.2
|
1.0
|
C29
|
A:LTZ201
|
2.7
|
26.9
|
1.0
|
C31
|
A:LTZ201
|
2.7
|
29.2
|
1.0
|
CE2
|
A:TYR100
|
3.6
|
23.3
|
1.0
|
OH
|
A:TYR100
|
3.7
|
23.8
|
1.0
|
CD2
|
A:HIS96
|
3.8
|
26.8
|
1.0
|
CG
|
A:HIS96
|
3.9
|
26.1
|
1.0
|
CZ
|
A:TYR100
|
3.9
|
23.4
|
1.0
|
CD2
|
A:LEU54
|
4.0
|
23.4
|
1.0
|
C28
|
A:LTZ201
|
4.0
|
28.7
|
1.0
|
C32
|
A:LTZ201
|
4.0
|
27.6
|
1.0
|
CB
|
A:HIS96
|
4.0
|
23.2
|
1.0
|
CD1
|
A:LEU54
|
4.1
|
27.2
|
1.0
|
CD1
|
A:ILE99
|
4.2
|
21.4
|
1.0
|
CA
|
A:HIS96
|
4.3
|
22.3
|
1.0
|
CG2
|
A:ILE99
|
4.4
|
20.4
|
1.0
|
NE2
|
A:HIS96
|
4.5
|
28.5
|
1.0
|
C27
|
A:LTZ201
|
4.5
|
28.2
|
1.0
|
CB
|
A:ILE99
|
4.5
|
20.0
|
1.0
|
CD2
|
A:TYR100
|
4.6
|
22.0
|
1.0
|
O
|
A:HIS96
|
4.6
|
22.4
|
1.0
|
ND1
|
A:HIS96
|
4.6
|
30.0
|
1.0
|
CG
|
A:LEU54
|
4.6
|
24.6
|
1.0
|
C
|
A:HIS96
|
4.9
|
22.0
|
1.0
|
CE1
|
A:HIS96
|
4.9
|
31.3
|
1.0
|
CG1
|
A:ILE99
|
5.0
|
21.4
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 3w69
Go back to
Chlorine Binding Sites List in 3w69
Chlorine binding site 2 out
of 4 in the Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl201
b:26.2
occ:1.00
|
CL1
|
A:LTZ201
|
0.0
|
26.2
|
1.0
|
C24
|
A:LTZ201
|
1.8
|
26.9
|
1.0
|
C25
|
A:LTZ201
|
2.7
|
26.1
|
1.0
|
C23
|
A:LTZ201
|
2.8
|
25.6
|
1.0
|
CD1
|
A:ILE61
|
3.6
|
22.9
|
1.0
|
CB
|
A:LEU57
|
3.8
|
21.8
|
1.0
|
CZ
|
A:PHE91
|
4.0
|
20.3
|
1.0
|
C26
|
A:LTZ201
|
4.0
|
24.1
|
1.0
|
C22
|
A:LTZ201
|
4.0
|
24.8
|
1.0
|
CE1
|
A:PHE91
|
4.1
|
19.5
|
1.0
|
CD1
|
A:LEU57
|
4.1
|
23.6
|
1.0
|
CD2
|
A:LEU54
|
4.3
|
23.4
|
1.0
|
CG2
|
A:ILE99
|
4.4
|
20.4
|
1.0
|
CD1
|
A:ILE99
|
4.5
|
21.4
|
1.0
|
CG
|
A:LEU57
|
4.5
|
22.9
|
1.0
|
C21
|
A:LTZ201
|
4.6
|
26.3
|
1.0
|
C
|
A:LEU57
|
4.7
|
21.6
|
1.0
|
N
|
A:GLY58
|
4.8
|
22.0
|
1.0
|
CA
|
A:LEU57
|
4.9
|
22.0
|
1.0
|
CE2
|
A:PHE86
|
5.0
|
19.7
|
1.0
|
O
|
A:LEU57
|
5.0
|
21.3
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 3w69
Go back to
Chlorine Binding Sites List in 3w69
Chlorine binding site 3 out
of 4 in the Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:29.6
occ:1.00
|
CL2
|
B:LTZ201
|
0.0
|
29.6
|
1.0
|
C30
|
B:LTZ201
|
1.8
|
28.8
|
1.0
|
C31
|
B:LTZ201
|
2.7
|
29.9
|
1.0
|
C29
|
B:LTZ201
|
2.8
|
27.3
|
1.0
|
CE1
|
B:TYR100
|
3.4
|
25.1
|
1.0
|
CZ
|
B:TYR100
|
3.4
|
27.4
|
1.0
|
ND1
|
B:HIS96
|
3.5
|
33.9
|
1.0
|
CG
|
B:HIS96
|
3.5
|
32.9
|
1.0
|
OH
|
B:TYR100
|
3.6
|
29.6
|
1.0
|
CB
|
B:HIS96
|
3.6
|
31.3
|
1.0
|
CA
|
B:HIS96
|
3.7
|
30.8
|
1.0
|
CG2
|
B:ILE99
|
3.7
|
25.2
|
1.0
|
O
|
B:HIS96
|
3.8
|
29.6
|
1.0
|
CB
|
B:ILE99
|
3.9
|
27.0
|
1.0
|
CD1
|
B:TYR100
|
3.9
|
25.6
|
1.0
|
CE2
|
B:TYR100
|
4.0
|
26.8
|
1.0
|
C32
|
B:LTZ201
|
4.0
|
28.8
|
1.0
|
C28
|
B:LTZ201
|
4.0
|
27.7
|
1.0
|
CE1
|
B:HIS96
|
4.2
|
33.9
|
1.0
|
C
|
B:HIS96
|
4.2
|
30.8
|
1.0
|
CD2
|
B:HIS96
|
4.2
|
32.0
|
1.0
|
CD2
|
B:LEU54
|
4.2
|
26.4
|
1.0
|
CG
|
B:TYR100
|
4.5
|
26.2
|
1.0
|
CD2
|
B:TYR100
|
4.5
|
26.0
|
1.0
|
CD1
|
B:ILE99
|
4.5
|
27.0
|
1.0
|
O
|
B:HOH301
|
4.5
|
36.1
|
1.0
|
NE2
|
B:HIS96
|
4.6
|
33.1
|
1.0
|
C27
|
B:LTZ201
|
4.6
|
28.8
|
1.0
|
CG1
|
B:ILE99
|
4.8
|
26.9
|
1.0
|
N
|
B:TYR100
|
4.9
|
27.1
|
1.0
|
N
|
B:HIS96
|
4.9
|
30.6
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 3w69
Go back to
Chlorine Binding Sites List in 3w69
Chlorine binding site 4 out
of 4 in the Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of Human MDM2 with A Dihydroimidazothiazole Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:25.3
occ:1.00
|
CL1
|
B:LTZ201
|
0.0
|
25.3
|
1.0
|
C24
|
B:LTZ201
|
1.8
|
22.8
|
1.0
|
C23
|
B:LTZ201
|
2.7
|
24.8
|
1.0
|
C25
|
B:LTZ201
|
2.8
|
20.8
|
1.0
|
CD1
|
B:ILE61
|
3.8
|
20.1
|
1.0
|
CZ
|
B:PHE91
|
3.8
|
21.4
|
1.0
|
CE1
|
B:PHE91
|
3.9
|
22.2
|
1.0
|
C22
|
B:LTZ201
|
4.0
|
24.7
|
1.0
|
CE2
|
B:PHE86
|
4.0
|
24.4
|
1.0
|
CB
|
B:LEU57
|
4.0
|
22.3
|
1.0
|
C26
|
B:LTZ201
|
4.1
|
21.4
|
1.0
|
CD1
|
B:LEU57
|
4.1
|
20.5
|
1.0
|
CG2
|
B:ILE99
|
4.1
|
25.2
|
1.0
|
CZ
|
B:PHE86
|
4.4
|
24.0
|
1.0
|
CG
|
B:LEU57
|
4.5
|
20.1
|
1.0
|
C21
|
B:LTZ201
|
4.5
|
24.7
|
1.0
|
CG1
|
B:ILE99
|
4.7
|
26.9
|
1.0
|
CD2
|
B:LEU57
|
4.8
|
20.3
|
1.0
|
CD1
|
B:ILE99
|
4.8
|
27.0
|
1.0
|
|
Reference:
M.Miyazaki,
H.Naito,
Y.Sugimoto,
K.Yoshida,
H.Kawato,
T.Okayama,
H.Shimizu,
M.Miyazaki,
M.Kitagawa,
T.Seki,
S.Fukutake,
Y.Shiose,
M.Aonuma,
T.Soga.
Synthesis and Evaluation of Novel Orally Active P53-MDM2 Interaction Inhibitors Bioorg.Med.Chem. V. 21 4319 2013.
ISSN: ISSN 0968-0896
PubMed: 23685175
DOI: 10.1016/J.BMC.2013.04.056
Page generated: Sun Jul 21 07:22:02 2024
|